Preventing Pneumococcal Disease

JANUARY 29, 2012
Populations at risk for developing pneumococcal disease, including seniors, can benefit from the preventive protection of vaccination. Many adults who are older than 65 years did not receive any vaccination against pneumococcal disease as a child. In addition, adults with comorbid conditions are at additional risk for developing pneumococcal infection, and should educate themselves on the benefits of vaccination for preventing potentially life-threatening illness.




SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.